GlassScriptPhysician profile
Asim Nisar
NPI 1487754743
$9,619.04
in general payments reported to CMS, 2019-2025
32 companies · $704 in 2025
The $704 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,256 · 2020: $1,290 · 2021: $1,336 · 2022: $912 · 2023: $1,217 · 2024: $904 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,825.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,430.24 | 2019-2025 | Impella |
| W. L. Gore & Associates, INC. | $1,221.02 | 2020-2024 | Gore Excluder Iliac Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boston Scientific Corporation | $1,068.90 | 2019-2024 | Watchman Access System, Stingray, Mamba |
| Janssen Pharmaceuticals, INC | $1,018.13 | 2019-2024 | Xarelto, Opsumit |
| Edwards Lifesciences Corporation | $876.69 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Hemosphere |
| Inari Medical, INC. | $483.23 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $401.91 | 2020-2024 | Cardiomems, Coroflow, Mitraclip |
| Novo Nordisk INC | $296.94 | 2022-2025 | Ozempic, Wegovy |
| Novartis Pharmaceuticals Corporation | $269.92 | 2019-2025 | |
| Amgen INC. | $201.01 | 2021-2025 | Repatha, Repatha |
| Heartflow, INC. | $168.42 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $167.44 | 2023 | Optimizer |
| Shockwave Medical, INC | $154.86 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Livanova USA, INC. | $108.49 | 2019-2023 | Lifesparc |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.63 | 2021-2025 | Jardiance |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $80.67 | 2022-2025 | Farxiga, Brilinta |
| Cook Medical LLC | $75.37 | 2024 | Cook |
| E.R. Squibb & Sons, L.L.C. | $65.73 | 2022-2025 | Camzyos, Eliquis |
| Bard Peripheral Vascular, INC. | $53.85 | 2021 | |
| Stryker Corporation | $50.26 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bridgebio Pharma, INC. | $49.69 | 2025 | Attruby |
| Pfizer INC. | $38.42 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $36.39 | 2023 | Opsumit, Uptravi |
| Kestra Medical Technology Services, INC. | $35.21 | 2024 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.03 | 2025 | Lifevest |
| Terumo Medical Corporation | $24.95 | 2023 | Tr Band |
| Esperion Therapeutics, INC. | $24.12 | 2025 | Nexletol |
| Philips North America LLC | $23.81 | 2023 | |
| Cvrx, INC. | $23.23 | 2025 | Barostim Neo System |
| Imperative Care, INC | $19.72 | 2025 | Symphony Catheter |
| Scpharmaceuticals INC. | $15.48 | 2024 | |
| Surmodics, INC. | $14.28 | 2023 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asim Nisar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.